#Coronaviruses

megan culler freeman md, phd

mcfreeID

You may have heard my conversation with @jasonbnpr on @NPR this weekend as to why kids make up a relatively low percentage of #COVID cases overall,

David Ascher

DrDavidAscher

Excited that COVID-3D has been published in Nature Genetics. This is a great piece of work from the group, but led especially @steffportelli @carlosmr12 @elston_neil and Moshe. This work was

Kulvinder Kaur MD

dockaurG

Pls read #SARSCoV2 immunology& subthreads for what media & “experts” are not telling youFacts-we have some pre-existing cross-protective immunity-basing herd immunity only on antibodies omits strong Tcell immunity-vaccine candid

Steve Place

stevenplace

HOW TO (safely) BE A 'RONA REFUGEE IN FLORIDA- thread - Lockdowns continue to ramp up across the northeast, and you may be sick of it by now.Let me show

Prof Francois Balloux

BallouxFrancois

Antibody-Dependent Enhancement (ADE) is a complex and poorly understood phenomenon, likely underpinned by different mechanisms, where binding of a virus to suboptimal antibodies enhances severity of the disease, rather than

ice9

__ice9

GS-441524 is substantially less toxic than remdesivir, far easier to synthesize, more soluble, and has essentially identical effects because remdesivir is apparently metabolized into it (in spite of having been

A.M.

bhalomanush

As we wait for vaccines, let’s not forget drugs. We still need effective drugs against SARS-CoV-2 (and other coronaviruses that will infect humans in the future).There is an approach that

Joseph Allen

j_g_allen

THREAD on positive #COVIDー19 developments(I try to keep a runny tally in my head - helps get through the days, knowing there is a light at the end)1. Therapeutics are

zolani simayi

zsimayi

Let me help you with this my friend. There's plenty of evidence. Your favourites, who like to block me, must not be lazy to read widely.Assist you and other who

Prof Francois Balloux

BallouxFrancois

New preprint. We assessed the source of T-cell X-reactivity to #SARSCoV2 in unexposed people. Previous exposure to 'common cold' endemic HCoVs plays at most a marginal role, and we found

Adam Kucharski

AdamJKucharski

There are now several studies out there that together give a useful indication of the possible role of pre-existing immunity (antibodies/T-cells etc.) in SARS-CoV-2 dynamics. A few thoughts/links... 1/ First,

Robin Monotti

robinmonotti

'Zinc is the key to a healthy immune system, blocking pathogens while preventing inflammation. We’ve known this since zinc deficiency symptoms were first reported in the 1960's.'https://medium.com/@leonardjpmail/think-zinc-9c1

Kevin R McCarthy

mccarthy_kr

Sharing this story. What a way to kick things off with @PittCVR How does a virus with a proofreading polymerase rapidly evolve? In the case of SARS-CoV-2 we believe that

Michael Lin, PhD-MD

michaelzlin

Here's a Christmas gift: Turkey says Sinovac's COVID vaccine is 91.25% effective. That's a prelim result based on

Onur Özgöde

ummodern

If there’s a lesson from the pandemic, it is that the US failed not because of central planning and coordination, but lack thereof.https://twitter.com/conor64/status/1346276342027849728 Wasn't going to do this thread, but

Prof. Akiko Iwasaki

VirusesImmunity

Inspired by this tweet by @TheMenacheryLab, I reached out to the wonderful colleagues at the @serimmune to see if the other mutations found in the B.1.1.7 variant would evade antibody

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.